Publikationen in Zusammenarbeit mit Forschern von Hospital de Galdakao - Usansolo (21)

2024

  1. Acetazolamide-induced pulmonary oedema: A disproportionality analysis from the EudraVigilance database

    British Journal of Clinical Pharmacology, Vol. 90, Núm. 7, pp. 1751-1755

  2. Incorporating the One Health philosophy into pharmacovigilanc: Pharmacovigilance

    British Journal of Clinical Pharmacology

  3. Intranasal esketamine and manic symptoms: A disproportionality analysis in EudraVigilance

    European Neuropsychopharmacology

2017

  1. Hiccups in Parkinson’s disease: an analysis of cases reported in the European pharmacovigilance database and a review of the literature

    European Journal of Clinical Pharmacology, Vol. 73, Núm. 9, pp. 1159-1164

2015

  1. Adverse reactions to antipsychotics in parkinson disease: An analysis of the Spanish Pharmacovigilance database

    Clinical Neuropharmacology, Vol. 38, Núm. 3, pp. 69-84

  2. Anticholinergic burden in Parkinson's disease inpatients

    European Journal of Clinical Pharmacology, Vol. 71, Núm. 10, pp. 1271-1277

2014

  1. Desafíos en el manejo farmacoterapéutico del paciente ingresado con enfermedad de Parkinson

    Revista de Neurologia, Vol. 58, Núm. 8, pp. 353-364

2013

  1. Antipsychotics and seizures: Higher risk with atypicals?

    Seizure, Vol. 22, Núm. 2, pp. 141-143

  2. Comments on Duran et al.'s systematic review of anticholinergic risk scales (EJCP 2DOI 10.1007/s00228-013-1499-3)

    European Journal of Clinical Pharmacology

  3. Eosinophilia associated with bupropion

    International Journal of Clinical Pharmacy, Vol. 35, Núm. 4, pp. 532-534

  4. Expert-based drug lists to measure anticholinergic burden: Similar names, different results

    Psychogeriatrics, Vol. 13, Núm. 1, pp. 17-24

2012

  1. Estimación de la tasa de filtración glomerular para el ajuste posológico de los fármacos. Reina la confusión

    Nefrologia

  2. Explicit appropriateness prescription criteria in advanced dementia. Are we there yet?

    European Geriatric Medicine

  3. Severe hypoglycemia associated with levofloxacin in an elderly diabetic inpatient

    European Geriatric Medicine, Vol. 3, Núm. 3, pp. 181-183

2011

  1. Antipsychotic induced symptomatic hyperprolactinemia: Are dopamine agonists safe?

    Psychopharmacology Bulletin, Vol. 44, Núm. 3, pp. 5

  2. Comentarios a la versión en español de los criterios "STOPP/START"

    Revista Espanola de Geriatria y Gerontologia

2008

  1. Antidopaminergic therapy for managing comorbidities in patients with Parkinson's disease

    American Journal of Health-System Pharmacy, Vol. 65, Núm. 5, pp. 414-419

2007

  1. Evaluación prospectiva de interacciones entre medicamentos en pacientes ingresados mediante una aplicación informática

    Farmacia Hospitalaria, Vol. 31, Núm. 2, pp. 93-100

2005

  1. Miliary tuberculosis following treatment with adalimumab [2]

    Farmacia Hospitalaria

2004

  1. Simplificación con lamivudina, zidovudina y abacavir: Repercusión sobre la adherencia, resultados clínicos e impacto económico

    Farmacia Hospitalaria, Vol. 28, Núm. 6 SUPPL. 1, pp. 27-33